Show pageBacklinksExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. El tratamiento del [[vasoespasmo|vasoespasmo]] con eritropoyetina en fase aguda, conduce a una reducción de vasoespasmo grave. Las [[estatina|estatinas]] pueden potenciar la neuroprotección por la eritropoyetina y parece atenuada por la vejez y la sepsis (Tseng 2009). Tseng MY, Hutchinson PJ, Kirkpatrick PJ. Interaction of neurovascular protection of erythropoietin with age, sepsis, and statin therapy following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2009 Nov 20. eritropoyetina.txt Last modified: 2025/05/13 02:13by 127.0.0.1